Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both
Titel:
Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both
Auteur:
Fox, Keith A.A. Anand, Sonia S. Aboyans, Victor Cowie, Martin R. Debus, E. Sebastian Zeymer, Uwe Monje, Danja VogtlÃĪnder, Kai Lawatscheck, Robert Gay, Alain